| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 441,052 | 937,516 | 801,304 | 827,088 | | Cost of Revenue | 508,721 | 708,528 | 771,747 | 532,272 | | | Gross Profit | (67,669) | 228,988 | 29,557 | 294,816 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (51,483) | 163,692 |
-
| 152,681 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 7,880 | 7,508 | 7,361 | 9,864 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (24,066) | 57,788 | 22,196 | 132,271 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,179 | 1,058 | 858 | 1,063 | | Earnings Before Interest And Taxes | (22,887) | 58,846 | 23,054 | 133,334 | | Interest Expense | 5,187 | 4,219 | 6,547 | 6,127 | | Income Before Tax | (28,074) | 54,627 | 16,507 | 127,207 | | Income Tax Expense | (12,262) | 19,897 | 5,245 | 48,860 | | Minority Interest |
-
| (514) | 514 |
-
| | | | Net Income From Continuing Ops | (14,335) | 35,517 | 11,776 | 78,787 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,335) | 35,517 | 11,776 | 78,787 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,335) | $35,517 | $11,776 | $78,787 |
|
0.29% Nasdaq 
0.16 (0.44%) 
Income Statement
